Evidence map›Paper›PMID 24987519›Full record

ArticleCilia2014

Loss of primary cilia occurs early in breast cancer development.

Ina Menzl, Lauren Lebeau, Ritu Pandey, Nadia B Hassounah, Frank W Li, Ray Nagle, Karen Weihs, Kimberly M McDermott

Open access · hybridAbstract read
In one paragraph

Article in Cilia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 147 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Illumination of understudied ciliary kinases.Frontiers in molecular biosciences · 2024
    Review
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Ina MenzlThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
Lauren LebeauDepartment of Pathology, University of Arizona Medical Center, Tucson, AZ, USA.
Ritu PandeyThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
Nadia B HassounahThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
Frank W LiDepartment of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
Ray NagleThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA ; Department of Pathology, University of Arizona Medical Center, Tucson, AZ, USA.
Karen WeihsThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA ; Department of Psychiatry, University of Arizona Medical Center, Tucson, AZ, USA.
Kimberly M McDermottThe University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA ; Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA ; Bio5 Institute, University of Arizona, Tucson, AZ, USA.
University of Arizona · USUniversity of Arizona Cancer CenterBanner - University Medical Center Tucson · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Dan Theodorescu · 1985 to 2026
$110.2M
6 · The paper itself

Abstract

backgroundPrimary cilia are microtubule-based organelles that protrude from the cell surface. Primary cilia play a critical role in development and disease through regulation of signaling pathways including the Hedgehog pathway. Recent mouse models have also linked ciliary dysfunction to cancer. However, little is known about the role of primary cilia in breast cancer development. Primary cilia expression was characterized in cancer cells as well as their surrounding stromal cells from 86 breast cancer patients by counting cilia and measuring cilia length. In addition, we examined cilia expression in normal epithelial and stromal cells from reduction mammoplasties as well as histologically normal adjacent tissue for comparison.

resultsWe observed a statistically significant decrease in the percentage of ciliated cells on both premalignant lesions as well as in invasive cancers. This loss of cilia does not correlate with increased proliferative index (Ki67-positive cells). However, we did detect rare ciliated cancer cells present in patients with invasive breast cancer and found that these express a marker of basaloid cancers that is associated with poor prognosis (Cytokeratin 5). Interestingly, the percentage of ciliated stromal cells associated with both premalignant and invasive cancers decreased when compared to stromal cells associated with normal tissue. To understand how cilia may be lost during cancer development we analyzed the expression of genes required for ciliogenesis and/or ciliary function and compared their expression in normal versus breast cancer samples. We found that expression of ciliary genes were frequently downregulated in human breast cancers.

conclusionsThese data suggest that primary cilia are lost early in breast cancer development on both the cancer cells and their surrounding stromal cells.

Indexed as

Cancer-associated stromaCarcinoma in situCilia lengthCiliogenesisInvasive breast cancerPrimary cilia

Identifiers

PMID24987519
PMCPMC4076761
OpenAlexW2145278939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.